Moleculin Biotech
MBRX
MBRX
15 hedge funds and large institutions have $918K invested in Moleculin Biotech in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$288K | |
| 2 | +$274K | |
| 3 | +$117K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$28K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
+$23.5K |
Top Sellers
| 1 | -$17K | |
| 2 | -$2K | |
| 3 | -$1K | |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
-$1K |